Digital Redefining pharmaceutical case processing in the age of AI a... Pharmaceutical case processing is witnessing a 15% annual increase in adverse event reports, according to
Sustainability Life sciences faces a battle with sustainability, but let’s ... We know that the global healthcare sector is a contributor to the warming of our planet.
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
